What is Sutro Biopharma's change in AR?

Sutro Biopharma (STRO) reported change in AR of $8.51M in Q1 2026.

How has Sutro Biopharma's change in AR changed year-over-year?

Sutro Biopharma's change in AR increased by 72.0% year-over-year, from $4.95M to $8.51M.

What is the long-term trend for Sutro Biopharma's change in AR?

Over 4 years (2021 to 2025), Sutro Biopharma's change in AR has grown at a -9.2% compound annual growth rate (CAGR), from $6.9M to -$4.69M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Sutro Biopharma STRO Change in AR

Change in AR at other companies

PfizerPFE

$65.75M+141%

Gilead SciencesGILD

-$134M-69.6%

RegenxbioRGNX

-$18.25M-1,061%

XencorXNCR

-$5.8M+75.2%

SchrodingerSDGR

-$55.79M+74.1%

CytomX TherapeuticsCTMX

-$1.37M-19.2%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's change in AR?: Sutro Biopharma (STRO) reported change in AR of $8.51M in Q1 2026.
How has Sutro Biopharma's change in AR changed year-over-year?: Sutro Biopharma's change in AR increased by 72.0% year-over-year, from $4.95M to $8.51M.
What is the long-term trend for Sutro Biopharma's change in AR?: Over 4 years (2021 to 2025), Sutro Biopharma's change in AR has grown at a -9.2% compound annual growth rate (CAGR), from $6.9M to -$4.69M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.